BioSpace News Archive

Albireo Pharma, Inc., a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, provided a business update and reported financial results for the third quarter ended September 30, 2019.

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, announced that the Company will host a conference call and live webcast on Wednesday, November 13, 2019 at 8:00 a.m.

Oncology Pharma Inc. is pleased to announce that it has entered into an agreement with Ribera for its clinical trial platform, “Connect2Med”.

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today provided a business update on its clinical development activities and reported its financial results for the third quarter ended September 30, 2019.

Net revenue of $7.2 million in the third quarter of 2019, representing 78% growth compared to the third quarter of 2018

Clinical responses with ADP-A2M4 in 7 out of 12 patients with synovial sarcoma, and clinical benefit in 11 out of 12 patients

Soliant primarily provides therapists, including speech pathologists, psychologists, occupational therapists and nurses, to K-12 schools.

The company will also host a conference call on Thursday, November 14, 2019 at 8:30 a.m. Eastern Time.

Ahlstrom-Munksjö announces the launch of TrustShield™, a versatile portfolio of medical fabrics that can be used to provide protection against surgical lasers, chemicals and potent chemotherapy drugs.

MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the Company will release its financial results for the third quarter ended September 30, 2019 at 7:00 am Eastern Time on Thursday, November 14, 2019.